Literature DB >> 22057511

Synaptic protein expression is regulated by a pro-oxidant diet in APPxPS1 mice.

Martin Broadstock1, Rikke Lewinsky, Emma L Jones, Cathy Mitchelmore, David R Howlett, Paul T Francis.   

Abstract

Dietary factors may play a role in Alzheimer's disease (AD) pathogenesis. In an effort to recapitulate some of the synaptic protein changes observed in the disease, AD transgenic and wild-type mice were fed either a normal or pro-oxidant diet for 3 months from three months of age. Pro-oxidant diet treatment resulted in altered expression of vesicular glutamate transporter-1 and glutamine synthetase, suggesting changes in glutamatergic synaptic function, and increased expression of urokinase plasminogen activator receptor, possibly reflecting oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057511     DOI: 10.1007/s00702-011-0727-1

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  29 in total

1.  Structural involvement of the glutamatergic presynaptic boutons in a transgenic mouse model expressing early onset amyloid pathology.

Authors:  K F S Bell; G J L de Kort; S Steggerda; R Shigemoto; A Ribeiro-da-Silva; A C Cuello
Journal:  Neurosci Lett       Date:  2003-12-19       Impact factor: 3.046

2.  Pro-oxidant diet enhances β/γ secretase-mediated APP processing in APP/PS1 transgenic mice.

Authors:  Fahd Choudhry; David R Howlett; Jill C Richardson; Paul T Francis; Robert J Williams
Journal:  Neurobiol Aging       Date:  2010-08-17       Impact factor: 4.673

3.  Oxidative stress in Alzheimer's disease.

Authors:  Ved Chauhan; Abha Chauhan
Journal:  Pathophysiology       Date:  2006-06-15

4.  The alternative role of 14-3-3 zeta as a sweeper of misfolded proteins in disease conditions.

Authors:  Kiyotoshi Kaneko; Naomi S Hachiya
Journal:  Med Hypotheses       Date:  2006-03-03       Impact factor: 1.538

5.  Increased expression of the urokinase plasminogen-activator receptor in amyloid beta peptide-treated human brain microglia and in AD brains.

Authors:  Douglas G Walker; Lih-Fen Lue; Thomas G Beach
Journal:  Brain Res       Date:  2002-02-01       Impact factor: 3.252

6.  Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model.

Authors:  Heng Du; Lan Guo; Shiqiang Yan; Alexander A Sosunov; Guy M McKhann; Shirley ShiDu Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

7.  Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer's disease-linked mutations in amyloid precursor protein and presenilin 1.

Authors:  Freya G G Vercauteren; Stefan Clerens; Line Roy; Nathalie Hamel; Lut Arckens; Frans Vandesande; Leena Alhonen; Juhani Janne; Moshe Szyf; A Claudio Cuello
Journal:  Brain Res Mol Brain Res       Date:  2004-12-20

Review 8.  Dietary factors and Alzheimer's disease.

Authors:  José A Luchsinger; Richard Mayeux
Journal:  Lancet Neurol       Date:  2004-10       Impact factor: 44.182

9.  Urokinase-type plasminogen activator receptor (uPAR) augments brain damage in a murine model of ischemic stroke.

Authors:  Nobuo Nagai; Kiyotaka Okada; Naoyuki Kawao; Chikako Ishida; Shigeru Ueshima; Desire Collen; Osamu Matsuo
Journal:  Neurosci Lett       Date:  2007-12-08       Impact factor: 3.046

10.  Amyloid beta-protein stimulates the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells.

Authors:  Judianne Davis; Matthew R Wagner; Weibing Zhang; Feng Xu; William E Van Nostrand
Journal:  J Biol Chem       Date:  2003-05-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.